A vaccine developed by Duke Human Vaccine Institute researchers that protects against three distinct fatal coronaviruses has shown success in animal studies, indicating the potential for pan-coronavirus immunisation.
A vaccine created by researchers at the Duke Human Vaccine Institute that protects against three separate lethal coronaviruses has shown success in mouse trials, suggesting the potential of a pan-coronavirus vaccination.